Damora Therapeutics (DMRA) Leases (2019 - 2025)
Damora Therapeutics posted quarterly Leases of $68000.0 for Q4 2025, down 6.85% year-on-year from $73000.0 in Q4 2024, and down 5.56% on a QoQ basis from $72000.0 in Q3 2025.
Damora Therapeutics (DMRA) has 7 years of Leases data on file, last reported at $68000.0 in Q4 2025.
- For the quarter ending Q4 2025, Leases fell 6.85% year-over-year to $68000.0; the trailing twelve-month figure through Dec 2025 stood at $68000.0 (down 6.85% YoY), and the FY2025 full-year result was $68000.0, down 6.85% from the prior year.
- Leases for Q4 2025 stood at $68000.0, down from $72000.0 in the prior quarter.
- Across five years, Leases topped out at $1.1 million in Q2 2021 and bottomed at $32000.0 in Q3 2024.
- The 5-year median for Leases is $503500.0 (2022), against an average of $467900.0.
- The widest annual swing landed in 2024, when Leases slumped 92.94%; it then soared 125.0% in 2025.
- A 5-year view of Leases shows it stood at $834000.0 in 2021, then dropped by 2.88% to $810000.0 in 2022, then slumped by 69.51% to $247000.0 in 2023, then tumbled by 70.45% to $73000.0 in 2024, then retreated by 6.85% to $68000.0 in 2025.
- The last three Leases figures came in at $68000.0 (Q4 2025), $72000.0 (Q3 2025), and $75000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 73,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Mar 31, 2024 | 152,000.00 |
| Dec 31, 2023 | 247,000.00 |
| Sep 30, 2023 | 453,000.00 |
| Jun 30, 2023 | 633,000.00 |
| Mar 31, 2023 | 704,000.00 |
| Dec 31, 2022 | 810,000.00 |
| Sep 30, 2022 | 852,000.00 |
| Jun 30, 2022 | 554,000.00 |
| Mar 31, 2022 | 702,000.00 |
| Dec 31, 2021 | 834,000.00 |
| Sep 30, 2021 | 940,000.00 |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | 933,000.00 |
| Dec 31, 2020 | 885,000.00 |
| Sep 30, 2020 | 905,000.00 |
| Dec 31, 2019 | 298,000.00 |